CUSIP 152309100SPONSORED ADSCNTAQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
146 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Medicxi Ventures Management (Jersey) Ltd | 19.96M | $499.28M | 0 | Held |
| 2 | Avoro Capital Advisors LLC | 14.56M | $364.03M | +3.75M | Added |
| 3 | Adage Capital Partners Gp, L.L.C. | 11.28M | $282.16M | +1.25M | Added |
| 4 | Index Venture Life Associates Vi Ltd | 9.96M |
| $249.14M |
| 0 |
| Held |
| 5 | Fmr LLC | 8.96M | $224.14M | +2.68M | Added |
| 6 | General Atlantic, L.P. | 6.12M | $153.00M | −3.56M | Reduced |
| 7 | Farallon Capital Management LLC | 5.38M | $134.48M | +1.05M | Added |
| 8 | Tcg Crossover Management, LLC | 4.29M | $107.20M | +1.15M | Added |
| 9 | Janus Henderson Group PLC | 4.09M | $102.39M | −1.31M | Reduced |
| 10 | Siren, L.L.C. | 4.03M | $100.73M | +800.0K | Added |
See every fund holding Centessa Pharmaceuticals PLC, with full quarter-over-quarter share changes.
Unlock all holders